Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a
Terry Ross has stepped down as president of Imatron, although he will remain a member of the board, focusing on strategic business development. His vacated position will not be filled, nor will his office, which Imatron has already turned into a library.
The position of president was created in 1998 as an enticement for Ross to lead the company. The agreement then was for Ross to stay just two years, long enough to redirect Imatron toward more profitable activities. He remained longer than initially planned. But for the last six weeks Ross has been on vacation. His retirement was not announced until Ross was satisfied that the company was functioning well without him.
CEO S. Lewis Meyer has taken over the helm.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.